NOTICE: This opinion is subject to formal revision before
publication in the preliminary print of the United States
Reports. Readers are requested to notify the Reporter of Decisions,
Supreme Court of the United States, Washington, D. C. 20543,
of any typographical or other formal errors, in order that
corrections may be made before the preliminary print goes to
press.
SUPREME COURT OF THE UNITED STATES
_________________
No. 13–435
_________________
OMNICARE, INC., et al., PETITIONERS
v. LABORERS
DISTRICT COUNCIL CONSTRUCTION INDUSTRY PENSION FUND et al.
on writ of certiorari to the united states court of appeals for
the sixth circuit
[March 24, 2015]
Justice Kagan delivered the opinion of the
Court.
Before a company may sell securities in interstate commerce, it
must file a registration statement with the Securities and Exchange
Commission (SEC). If that document either “contain[s] an untrue
statement of a material fact” or “omit[s] to state a material fact
. . . necessary to make the statements therein not
misleading,” a purchaser of the stock may sue for damages. 15
U. S. C. §77k(a). This case requires us to decide how
each of those phrases applies to statements of opinion.
I
The Securities Act of 1933, 48Stat. 74, 15 U. S. C.
§77a
et seq., protects investors by ensuring that
companies issuing securities (known as “issuers”) make a “full and
fair disclosure of information” relevant to a public offering.
Pinter v.
Dahl, 486 U. S. 622, 646 (1988) . The
linchpin of the Act is its registration requirement. With limited
exceptions not relevant here, an issuer may offer securities to the
public only after filing a registration statement. See §§77d, 77e.
That statement must contain specified information about both the
company itself and the security for sale. See §§77g, 77aa. Beyond
those required disclosures, the issuer may include additional
representations of either fact or opinion.
Section 11 of the Act promotes compliance with these disclosure
provisions by giving purchasers a right of action against an issuer
or designated individuals (directors, partners, underwriters, and
so forth) for material misstatements or omissions in registration
statements. As relevant here, that section provides:
“In case any part of the registration statement, when such part
became effective, contained an untrue statement of a material fact
or omitted to state a material fact required to be stated therein
or necessary to make the statements therein not misleading, any
person acquiring such security . . . [may] sue.”
§77k(a).
Section 11 thus creates two ways to hold issuers liable for the
contents of a registration statement—one focusing on what the
statement says and the other on what it leaves out. Either way, the
buyer need not prove (as he must to establish certain other
securities offenses) that the defendant acted with any intent to
deceive or defraud.
Herman & MacLean v.
Huddleston, 459 U. S. 375 –382 (1983).
This case arises out of a registration statement that petitioner
Omnicare filed in connection with a public offering of common
stock. Omnicare is the nation’s largest provider of pharmacy
services for residents of nursing homes. Its registration statement
contained (along with all mandated disclosures) analysis of the
effects of various federal and state laws on its business model,
including its acceptance of rebates from pharmaceutical
manufacturers. See,
e.g., App. 88–107, 132–140, 154–166. Of
significance here, two sentences in the registration statement
expressed Omnicare’s view of its compliance with legal
requirements:
“We believe our contract arrangements with other healthcare
providers, our pharmaceutical suppliers and our pharmacy practices
are in compliance with applicable federal and state laws.”
Id., at 95.
“We believe that our contracts with pharmaceutical manufacturers
are legally and economically valid arrangements that bring value to
the healthcare system and the patients that we serve.”
Id.,
at 137.
Accompanying those legal opinions were some caveats. On the same
page as the first statement above, Omnicare mentioned several
state-initiated “enforcement actions against pharmaceutical
manufacturers” for offering payments to pharmacies that dispensed
their products; it then cautioned that the laws relating to that
practice might “be interpreted in the future in a manner
inconsistent with our interpretation and application.”
Id.,
at 96. And adjacent to the second statement, Omnicare noted that
the Federal Government had expressed “significant concerns” about
some manufacturers’ rebates to pharmacies and warned that business
might suffer “if these price concessions were no longer provided.”
Id., at 136–137.
Respondents here, pension funds that purchased Omnicare stock in
the public offering (hereinafter Funds), brought suit alleging that
the company’s two opinion statements about legal compliance give
rise to liability under §11. Citing lawsuits that the Federal
Government later pressed against Omnicare, the Funds’ complaint
maintained that the company’s receipt of payments from drug
manufacturers violated anti-kickback laws. See
id., at
181–186, 203–226. Accordingly, the complaint asserted, Omnicare
made “materially false” representations about legal compliance.
Id., at 274. And so too, the complaint continued, the
company “omitted to state [material] facts necessary” to make its
representations not misleading.
Id., at 273. The Funds
claimed that none of Omnicare’s officers and directors “possessed
reasonable grounds” for thinking that the opinions offered were
truthful and complete.
Id., at 274. Indeed, the complaint
noted that one of Omnicare’s attorneys had warned that a particular
contract “carrie[d] a heightened risk” of liability under
anti-kickback laws.
Id., at 225 (emphasis deleted). At the
same time, the Funds made clear that in light of §11’s strict
liability standard, they chose to “exclude and disclaim any
allegation that could be construed as alleging fraud or intentional
or reckless misconduct.”
Id., at 273.
The District Court granted Omnicare’s motion to dismiss. See
Civ. No. 2006–26 (ED Ky., Feb. 13, 2012), App. to Pet. for Cert.
28a, 38a–40a, 2012 WL 462551, *4–*5. In the court’s view,
“statements regarding a company’s belief as to its legal compliance
are considered ‘soft’ information” and are actionable only if those
who made them “knew [they] were untrue at the time.” App. to Pet.
for Cert. 38a. The court concluded that the Funds’ complaint failed
to meet that standard because it nowhere claimed that “the
company’s officers knew they were violating the law.”
Id.,
at 39a. The Court of Appeals for the Sixth Circuit reversed. See
719 F. 3d 498 (2013). It acknowledged that the two statements
highlighted in the Funds’ complaint expressed Omnicare’s “opinion”
of legal compliance, rather than “hard facts.”
Id., at 504
(quoting
In re Sofamor Danek Group Inc., 123 F. 3d
394, 401–402 (CA6 1997)). But even so, the court held, the Funds
had to allege only that the stated belief was “objectively false”;
they did not need to contend that anyone at Omnicare “disbelieved
[the opinion] at the time it was expressed.” 719 F. 3d
,
at 506 (quoting
Fait v.
Regions Financial Corp., 655
F. 3d 105, 110 (CA2 2011)).
We granted certiorari, 571 U. S. ___ (2014), to consider
how §11 pertains to statements of opinion. We do so in two steps,
corresponding to the two parts of §11 and the two theories in the
Funds’ complaint. We initially address the Funds’ claim that
Omnicare made “untrue statement[s] of . . . material
fact” in offering its views on legal compliance. §77k(a); see App.
273–274. We then take up the Funds’ argument that Omnicare “omitted
to state a material fact . . . necessary to make the
statements [in its registration filing] not misleading.” §77k(a);
see App. 273–274. Unlike both courts below, we see those
allegations as presenting different issues.[
1] In
resolving the first, we discuss when an opinion itself constitutes
a factual misstatement. In analyzing the second, we address when an
opinion may be rendered misleading by the omission of discrete
factual representations. Because we find that the Court of Appeals
applied the wrong standard, we vacate its decision.
II
The Sixth Circuit held, and the Funds now urge, that a statement
of opinion that is ultimately found incorrect—even if believed at
the time made—may count as an “untrue statement of a material
fact.” 15 U. S. C §77k(a); see 719 F. 3d, at 505;
Brief for Respondents 20–26. As the Funds put the point, a
statement of belief may make an implicit assertion about the
belief’s “subject matter”: To say “we believe X is true” is often
to indicate that “X is in fact true.”
Id., at 23; see Tr. of
Oral Arg. 36. In just that way, the Funds conclude, an issuer’s
statement that “we believe we are following the law” conveys that
“we in fact are following the law”—which is “materially false,” no
matter what the issuer thinks, if instead it is violating an
anti-kickback statute. Brief for Respondents 1.
But that argument wrongly conflates facts and opinions. A fact
is “a thing done or existing” or “[a]n actual happening.” Webster’s
New International Dictionary 782 (1927). An opinion is “a belief[,]
a view,” or a “sentiment which the mind forms of persons or
things.”
Id., at 1509. Most important, a statement of fact
(“the coffee is hot”) expresses certainty about a thing, whereas a
statement of opinion (“I think the coffee is hot”) does not. See
ibid. (“An opinion, in ordinary usage . . . does
not imply . . . definiteness . . . or
certainty”); 7 Oxford English Dictionary 151 (1933) (an opinion
“rests[s] on grounds insufficient for complete demonstration”).
Indeed, that difference between the two is so ingrained in our
everyday ways of speaking and thinking as to make resort to old
dictionaries seem a mite silly. And Congress effectively
incorporated just that distinction in §11’s first part by exposing
issuers to liability not for “untrue statement[s]” full stop (which
would have included ones of opinion), but only for “untrue
statement[s] of . . .
fact.” §77k(a) (emphasis
added).
Consider that statutory phrase’s application to two hypothetical
statements, couched in ways the Funds claim are equivalent. A
company’s CEO states: “The TVs we manufacture have the highest
resolution available on the market.” Or, alternatively, the CEO
transforms that factual statement into one of opinion: “I
believe” (or “I think”) “the TVs we manufacture have the
highest resolution available on the market.” The first version
would be an untrue statement of fact if a competitor had introduced
a higher resolution TV a month before—even assuming the CEO had not
yet learned of the new product. The CEO’s assertion, after all, is
not mere puffery, but a determinate, verifiable statement about her
company’s TVs; and the CEO, however innocently, got the facts
wrong. But in the same set of circumstances, the second version
would remain true. Just as she said, the CEO really did believe,
when she made the statement, that her company’s TVs had the
sharpest picture around. And although a plaintiff could later prove
that opinion erroneous, the words “I believe” themselves admitted
that possibility, thus precluding liability for an untrue statement
of fact. That remains the case if the CEO’s opinion, as here,
concerned legal compliance. If, for example, she said, “I believe
our marketing practices are lawful,” and actually did think that,
she could not be liable for a false statement of fact—even if she
afterward discovered a longtime violation of law. Once again, the
statement would have been true, because all she expressed was a
view, not a certainty, about legal compliance.
That still leaves some room for §11’s false-statement provision
to apply to expressions of opinion. As even Omnicare acknowledges,
every such statement explicitly affirms one fact: that the speaker
actually holds the stated belief. See Brief for Petitioners 15–16;
W. Keeton, D. Dobbs, R. Keeton, & D. Owen, Prosser and Keeton
on the Law of Torts §109, p. 755 (5th ed. 1984) (Prosser and
Keeton) (“[A]n expression of opinion is itself always a statement
of . . . the fact of the belief, the existing state of
mind, of the one who asserts it”). For that reason, the CEO’s
statement about product quality (“I believe our TVs have the
highest resolution available on the market”) would be an untrue
statement of fact—namely, the fact of her own belief—if she knew
that her company’s TVs only placed second. And so too the statement
about legal compliance (“I believe our marketing practices are
lawful”) would falsely describe her own state of mind if she
thought her company was breaking the law. In such cases, §11’s
first part would subject the issuer to liability (assuming the
misrepresentation were material).[
2]
In addition, some sentences that begin with opinion words like
“I believe” contain embedded statements of fact—as, once again,
Omnicare recognizes. See Reply Brief 6. Suppose the CEO in our
running hypothetical said: “I believe our TVs have the highest
resolution available because we use a patented technology to which
our competitors do not have access.” That statement may be read to
affirm not only the speaker’s state of mind, as described above,
but also an underlying fact: that the company uses a patented
technology. See
Virginia Bankshares, Inc. v.
Sandberg, 501 U. S. 1083, 1109 (1991) (Scalia, J.,
concurring in part and concurring in judgment) (showing that a
statement can sometimes be “most fairly read as affirming
separately both the fact of the [speaker’s] opinion and the
accuracy of the facts” given to support or explain it (emphasis
deleted)). Accordingly, liability under §11’s false-statement
provision would follow (once again, assuming materiality) not only
if the speaker did not hold the belief she professed but also if
the supporting fact she supplied were untrue.
But the Funds cannot avail themselves of either of those ways of
demonstrating liability. The two sentences to which the Funds
object are pure statements of opinion: To simplify their content
only a bit, Omnicare said in each that “we believe we are obeying
the law.” And the Funds do not contest that Omnicare’s opinion was
honestly held. Recall that their complaint explicitly “exclude[s]
and disclaim[s]” any allegation sounding in fraud or deception.
App. 273. What the Funds instead claim is that Omni-care’s belief
turned out to be wrong—that whatever the company thought, it was in
fact violating anti-kickback laws. But that allegation alone will
not give rise to liability under §11’s first clause because, as we
have shown, a sincere statement of pure opinion is not an “untrue
statement of material fact,” regardless whether an investor can
ultimately prove the belief wrong. That clause, limited as it is to
factual statements, does not allow investors to second-guess
inherently subjective and uncertain assessments. In other words,
the provision is not, as the Court of Appeals and the Funds would
have it, an invitation to Monday morning quarterback an issuer’s
opinions.
III
A
That conclusion, however, does not end this case because the
Funds also rely on §11’s omissions provision, alleging that
Omnicare “omitted to state facts necessary” to make its opinion on
legal compliance “not misleading.” App. 273; see §77k(a).[
3] As all parties accept, whether a statement is
“misleading” depends on the perspective of a reasonable investor:
The inquiry (like the one into materiality) is objective. Cf.
TSC Industries, Inc. v.
Northway, Inc., 426
U. S. 438, 445 (1976) (noting that the securities laws care
only about the “significance of an omitted or misrepresented fact
to a reasonable investor”). We therefore must consider when, if
ever, the omission of a fact can make a statement of opinion like
Omnicare’s, even if literally accurate, misleading to an ordinary
investor.
Omnicare claims that is just not possible. On its view, no
reasonable person, in any context, can understand a pure statement
of opinion to convey anything more than the speaker’s own mindset.
See Reply Brief 5–6. As long as an opinion is sincerely held,
Omnicare argues, it cannot mislead as to any matter, regardless
what related facts the speaker has omitted. Such statements of
belief (concludes Omnicare) are thus immune from liability under
§11’s second part, just as they are under its first.[
4]
That claim has more than a kernel of truth. A reason-able person
understands, and takes into account, the differ-ence we have
discussed above between a statement of fact and one of opinion. See
supra, at 6–7. She recognizes the import of words like “I
think” or “I believe,” and grasps that they convey some lack of
certainty as to the statement’s content. See,
e.g.,
Restatement (Second) of Contracts §168, Comment
a, p. 456
(1979) (noting that a statement of opinion “implies that [the
speaker] . . . is not certain enough of what he says” to
do without the qualifying language). And that may be especially so
when the phrases appear in a registration statement, which the
reasonable investor expects has been carefully wordsmithed to
comply with the law. When reading such a document, the investor
thus distinguishes between the sentences “we believe X is true” and
“X is true.” And because she does so, the omission of a fact that
merely rebuts the latter statement fails to render the former
misleading. In other words, a statement of opinion is not
misleading just because external facts show the opinion to be
incorrect. Reasonable investors do not understand such statements
as guarantees, and §11’s omissions clause therefore does not treat
them that way.
But Omnicare takes its point too far, because a reason-able
investor may, depending on the circumstances, under-stand an
opinion statement to convey facts about how the speaker has formed
the opinion—or, otherwise put, about the speaker’s basis for
holding that view. And if the real facts are otherwise, but not
provided, the opinion statement will mislead its audience. Consider
an unadorned statement of opinion about legal compliance: “We
believe our conduct is lawful.” If the issuer makes that statement
without having consulted a lawyer, it could be misleadingly
incomplete. In the context of the securities market, an investor,
though recognizing that legal opinions can prove wrong in the end,
still likely expects such an assertion to rest on some meaningful
legal inquiry—rather than, say, on mere intuition, however
sincere.[
5] Similarly, if the issuer made the
statement in the face of its lawyers’ contrary advice, or with
knowledge that the Federal Government was taking the opposite view,
the investor again has cause to complain: He expects not just that
the issuer believes the opinion (however irrationally), but that it
fairly aligns with the information in the issuer’s possession at
the time.[
6] Thus, if a registration statement
omits material facts about the issuer’s inquiry into or knowledge
concerning a statement of opinion, and if those factsconflict with
what a reasonable investor would take from the statement itself,
then §11’s omissions clause creates liability.[
7]
An opinion statement, however, is not necessarily misleading
when an issuer knows, but fails to disclose, some fact cutting the
other way. Reasonable investors understand that opinions sometimes
rest on a weighing of competing facts; indeed, the presence of such
facts is one reason why an issuer may frame a statement as an
opinion, thus conveying uncertainty. See
supra, at 6–7, 11.
Suppose, for example, that in stating an opinion about legal
compliance, the issuer did not disclose that a single junior
attorney expressed doubts about a practice’s legal-ity, when six of
his more senior colleagues gave a stamp of approval. That omission
would not make the statement of opinion misleading, even if the
minority position ulti-mately proved correct: A reasonable investor
does not expect that
every fact known to an issuer supports
its opinion statement.[
8]
Moreover, whether an omission makes an expression of opinion
misleading always depends on context. Registration statements as a
class are formal documents, filed with the SEC as a legal
prerequisite for selling securities to the public. Investors do
not, and are right not to, expect opinions contained in those
statements to reflect baseless, off-the-cuff judgments, of the kind
that an individual might communicate in daily life. At the same
time, an investor reads each statement within such a document,
whether of fact or of opinion, in light of all its surrounding
text, including hedges, disclaimers, and apparently conflicting
information. And the investor takes into account the customs and
practices of the relevant industry. So an omission that renders
misleading a statement of opinion when viewed in a vacuum may not
do so once that statement is considered, as is appropriate, in a
broader frame. The reasonable investor understands a statement of
opinion in its full context, and §11 creates liability only for the
omission of material facts that cannot be squared with such a fair
reading.
These principles are not unique to §11: They inhere, too, in
much common law respecting the tort of misrepresentation.[
9] The Restatement of Torts, for example, recognizes that
“[a] statement of opinion as to facts not disclosed and not
otherwise known to the recipient may” in some circumstances
reasonably “be interpreted by him as an implied statement” that the
speaker “knows facts sufficient to justify him in forming” the
opinion, or that he at least knows no facts “incompatible with
[the] opinion.” Restatement (Second) of Torts §539, p. 85
(1976).[
10] When that is so, the Restatement
explains, liability may result from omission of facts—for example,
the fact that the speaker failed to conduct any investigation—that
rebut the recipient’s predictable inference. See
id.,
Comment
a, at 86;
id., Comment
b, at 87.
Similarly, the leading treatise in the area explains that “it has
been recognized very often that the expression of an opinion may
carry with it an implied assertion, not only that the speaker knows
no facts which would preclude such an opinion, but that he does
know facts which justify it.” Prosser and Keeton §109, at 760. That
is especially (and traditionally) the case, the treatise continues,
where—as in a registration statement—a speaker “holds himself out
or is understood as having special knowledge of the matter which is
not available to the plaintiff.”
Id., at 760–761 (footnote
omitted); see Restatement (Second) of Torts §539, Comment
b,
at 86 (noting that omissions relating to an opinion’s basis are
“particularly” likely to give rise to liability when the speaker
has “special knowledge of facts unknown to the recipient”);
Smith v.
Land and House Property Corp., [1884] 28 Ch.
D. 7, 15 (App. Cas.) (appeal taken from Eng.) (opinion of Bowen,
L. J.) (When “the facts are not equally known to both sides,
then a statement of opinion by the one who knows the facts best
. . . impliedly states that [the speaker] knows facts
which justify his opinion”).[
11]
And the purpose of §11 supports this understanding of how the
omissions clause maps onto opinion statements. Congress adopted §11
to ensure that issuers “tell[ ] the whole truth” to investors.
H. R. Rep. No. 85, 73d Cong., 1st Sess., 2 (1933) (quoting
President Roosevelt’s message to Congress). For that reason,
literal accuracy is not enough: An issuer must as well desist from
misleading investors by saying one thing and holding back another.
Omnicare would nullify that statutory requirement for all sentences
starting with the phrases “we believe” or “we think.” But those
magic words can preface nearly any conclusion, and the resulting
statements, as we have shown, remain perfectly capable of
misleading investors. See
supra, at 11–12. Thus, Omnicare’s
view would punch a hole in the statute for half-truths in the form
of opinion statements. And the difficulty of showing that such
statements are literally false—which requires proving an issuer did
not believe them, see
supra, at 7–8—would make that opening
yet more consequential: Were Omni-care right, companies would have
virtual
carte blanche to assert opinions in registration
statements free from worry about §11. That outcome would ill-fit
Congress’s decision to establish a strict liability offense
promoting “full and fair disclosure” of material information.
Pinter, 486 U. S., at 646; see
supra, at
1–2.
Omnicare argues, in response, that applying §11’s omissions
clause in the way we have described would have “adverse policy
consequences.” Reply Brief 17 (capitalization omitted). According
to Omnicare, any inquiry into the issuer’s basis for holding an
opinion is “hopelessly amorphous,” threatening “unpredictable” and
possibly “massive” liability.
Id., at 2; Brief for
Petitioners 34, 36. And because that is so, Omnicare claims, many
issuers will choose not to disclose opinions at all, thus
“depriving [investors] of potentially helpful information.” Reply
Brief 19; see Tr. of Oral Arg. 59–61.
But first, that claim is, just as Omnicare labels it, one of
“policy”; and Congress gets to make policy, not the courts. The
decision Congress made, for the reasons we have indicated, was to
extend §11 liability to all statements rendered misleading by
omission. In doing so, Congress no doubt made §11 less cut-and-dry
than a law prohibiting only false factual statements. Section 11’s
omissions clause, as applied to statements of both opinion and
fact, necessarily brings the reasonable person into the analysis,
and asks what she would naturally understand a statement to convey
beyond its literal meaning. And for expressions of opinion, that
means considering the foundation she would expect an issuer to have
before making the statement. See
supra, at 11–12. All that,
however, is a feature, not a bug, of the omissions provision.
Moreover, Omnicare way overstates both the looseness of the
inquiry Congress has mandated and the breadth of liability that
approach threatens. As we have explained, an investor cannot state
a claim by alleging only that an opinion was wrong; the complaint
must as well call into question the issuer’s basis for offering the
opinion. See
supra, at 11–12. And to do so, the investor
cannot just say that the issuer failed to reveal its basis. Section
11’s omissions clause, after all, is not a general disclosure
requirement; it affords a cause of action only when an issuer’s
failure to include a material fact has rendered a published
statement misleading. To press such a claim, an investor must
allege that kind of omission—and not merely by means of conclusory
assertions. See
Ashcroft v.
Iqbal, 556 U. S. 662, 678
(2009) (“Threadbare recitals of the elements of a cause of action,
supported by mere conclusory statements, do not suffice”). To be
specific: The investor must identify particular (and material)
facts going to the basis for the issuer’s opinion—facts about the
inquiry the issuer did or did not conduct or the knowledge it did
or did not have—whose omission makes the opinion statement at issue
misleading to a reasonable person reading the statement fairly and
in context. See
supra, at 11–14. That is no small task for
an investor.
Nor does the inquiry such a complaint triggers ask anything
unusual of courts. Numerous legal rules hinge on what a reasonable
person would think or expect. In requiring courts to view
statements of opinion from an ordinary investor’s perspective,
§11’s omissions clause demands nothing more complicated or
unmanageable. Indeed, courts have for decades engaged in just that
inquiry, with no apparent trouble, in applying the common law of
misrepresentation. See
supra, at 14–15.
Finally, we see no reason to think that liability for misleading
opinions will chill disclosures useful to investors. Nothing
indicates that §11’s application to misleading factual assertions
in registration statements has caused such a problem. And likewise,
common-law doctrines of opinion liability have not, so far as
anyone knows, deterred merchants in ordinary commercial
transactions from asserting helpful opinions about their products.
That absence of fallout is unsurprising. Sellers (whether of stock
or other items) have strong economic incentives to . . .
well,
sell (
i.e., hawk or peddle). Those market-based
forces push back against any inclination to underdisclose. And to
avoid exposure for omissions under §11, an issuer need only divulge
an opinion’s basis, or else make clear the real tentativeness of
its belief. Such ways of conveying opinions so that they do not
mislead will keep valuable information flowing. And that is the
only kind of information investors need. To the extent our decision
today chills
misleading opinions, that is all to the good:
In enacting §11, Congress worked to ensure better, not just more,
information.
B
Our analysis on this score counsels in favor of sending the case
back to the lower courts for decision. Neither court below
considered the Funds’ omissions theory with the right standard in
mind—or indeed, even recognized the distinct statutory questions
that theory raises. See
supra, at 4–5. We therefore follow
our ordinary practice of remanding for a determination of whether
the Funds have stated a viable omissions claim (or, if not, whether
they should have a chance to replead).
In doing so, however, we reemphasize a few crucial points
pertinent to the inquiry on remand. Initially, as we have said, the
Funds cannot proceed without identifying one or more facts left out
of Omnicare’s registration statement. See
supra, at 17–18.
The Funds’ recitation of the statutory language—that Omnicare
“omitted to state facts necessary to make the statements made not
misleading”—is not sufficient; neither is the Funds’ conclusory
allegation that Omnicare lacked “reasonable grounds for the belief”
it stated respecting legal compliance. App. 273–274. At oral
argument, however, the Funds highlighted another, more specific
allegation in their complaint: that an attorney had warned Omnicare
that a particular contract “carrie[d] a heightened risk” of legal
exposure under anti-kickback laws.
Id., at 225 (emphasis
omitted); see Tr. of Oral Arg. 42, 49;
supra, at 4. On
remand, the court must review the Funds’ complaint to determine
whether it adequately alleged that Omnicare had omitted that
(purported) fact, or any other like it, from the registration
statement. And if so, the court must determine whether the omitted
fact would have been material to a reasonable investor—
i.e.,
whether “there is a substantial likelihood that a reasonable
[investor] would consider it important.”
TSC Industries, 426
U. S., at 449.
Assuming the Funds clear those hurdles, the court must ask
whether the alleged omission rendered Omnicare’s legal compliance
opinions misleading in the way described earlier—
i.e.,
because the excluded fact shows that Omnicare lacked the basis for
making those statements that a reasonable investor would expect.
See
supra, at 11–12. Insofar as the omitted fact at issue is
the attorney’s warning, that inquiry entails consideration of such
matters as the attorney’s status and expertise and other legal
information available to Omnicare at the time. See
supra, at
13. Further, the analysis of whether Omnicare’s opinion is
misleading must address the statement’s context. See
supra,
at 14. That means the court must take account of whatever facts
Omnicare
did provide about legal compliance, as well as any
other hedges, disclaimers, or qualifications it included in its
registration statement. The court should consider, for example, the
information Omnicare offered that States had initiated enforcement
actions against drug manufacturers for giving rebates to
pharmacies, that the Federal Government had expressed concerns
about the practice, and that the relevant laws “could “be
interpreted in the future in a manner” that would harm Omnicare’s
business. See App. 95–96, 136–137;
supra, at 3.
* * *
With these instructions and for the reasons stated, we vacate
the judgment below and remand the case for further proceedings.
It is so ordered.
Comments
Be the first to comment
Leave a Comment